Regardless of the ROI of tissue structure, there was a consistent upregulation of genes including B2M, DDX60, HLA-B, PSMB8, PSMB9, PSME2, STAT1, STAT2, and TNFRSF21 in COVID-19 lungs. This evidence concerns the gene B2M and COVID-19.